CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Drugs Made In America Acquisition II Corp.
Sign in to watch- Ticker
- DMII
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 954-870-3104
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMII Ordinary Shares Nasdaq
- DMIIR Right Nasdaq
- DMIIU Unit Nasdaq
- NT 10-K Other NT 10-K
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
Page 1 of 1 · 8 filings